NEUROPROTECTION BY INDOLACTAM V AND DERIVATIVES THEREOF

摘要

2088514 9202137 PCTABS00010 A method for reducing adverse effects of neurotoxic injury, which comprises administering to a patient susceptible to neurotoxic injury an effective amount, sufficient to reduce the injury, of a compound having an indolactam V ring system. Particularly preferred are compounds having ring stereochemistry as indicated in formula (I). The indicated substituents show preferred locations of substituents; preferred substituents are defined in the specification.